Cascading layoffs that accelerated the decline · Fatal mistake: Medical loss ratios exceeded 100% across multiple markets as claims costs outpaced premiums — the business model was structurally loss-making at every market entered
Evaluating only Bright Health’s profile at its peak — without knowing the outcome — the model ranked Unit economics as the #1 likely cause. That’s exactly how it died.
Key Events Timeline
FOUNDING
Bright Health founded
FOUNDING
Bright Health founded
DOWN ROUND
Down round or bridge financing
DOWN ROUND
Down round or bridge financing
SHUTDOWN
Slow Death: Bright Health ceases operations
SHUTDOWN
Slow Death: Bright Health ceases operations
Full Analysis
Free · no account needed
Documented cause
Bright Health was founded in 2016 by Bob Sheehy (former Aetna President), Tom Valdivia, and Cynthia Lamont in Minneapolis to build a technology-enabled health insurance company. The company raised approximately $1.5B from investors before its June 2021 IPO at $18 per share, reaching a peak market cap of approximately $11.3B. Bright Health grew rapidly by offering competitive Medicare Advantage and ACA marketplace plans in multiple states. The collapse was actuarial: the company's medical loss ratio — the percentage of premiums paid out in medical claims — exceeded 100% in multiple markets, meaning Bright Health was paying more in claims than it collected in premiums. Rising healthcare costs post-COVID, an inability to accurately underwrite risk at scale, and competition for patients in markets with adverse selection drove losses. By 2022, Bright Health had exited all commercial insurance markets. In February 2023, Bright Health filed Chapter 11 for its California operations. The stock fell from $18 to approximately $0.50. Total capital of approximately $2.4B was consumed.
Alternative account: Bright Health was founded by former UnitedHealth Group executives with the thesis that technology-enabled health insurance, tightly integrated with provider networks, would achieve better outcomes and lower costs. The company raised $1.5B and IPO'd in June 2021 at an $11B valuation. But Bright's medical loss ratios were catastrophic: it lost $1.2B in 2021 and $1.2B in 2022. Unable to price adequately to cover claims while remaining competitive on ACA exchanges, Bright exited most states in 2022 and sold its insurance operations in 2023. The company survived as a shell with its NeueHealth provider subsidiary.
Lesson
“Health insurance is actuarial science, not technology disruption. A medical loss ratio above 100% is not a scaling problem — it is proof that the product is priced below cost.
Alternative account: Healthcare insurtech startups must answer one question before raising growth capital: "Can we price competitively on the exchange AND achieve better-than-industry loss ratios?" If the answer depends on a future operational improvement that hasn't been demonstrated at scale, the growth capital will accelerate losses, not solve them.”
Failure anatomy
Collapse type
Mass Layoff Spiral
📉 MEDIUM
Hype cycle
insurtech health plan hype 2018-2021
Moat type
Technology (technology-enabled health plan management)
Fatal mistake
Medical loss ratios exceeded 100% across multiple markets as claims costs outpaced premiums — the business model was structurally loss-making at every market entered